Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yukari Kujime"'
Autor:
Takehide Murata, Bingbing Liu, Hatsumi Nakata, Jianzhi Pan, Megumi Hirose, Izumu Saito, Sanae Inamoto, Hideyo Ugai, Kazunari K. Yokoyama, Yukari Kujime, Koji Nakade, Erika Suzuki, Makoto Kimura, Yoshinori Nagamura, Kumiko Inabe, Yoshihiro Ugawa, Takahito Yamasaki, Hirofumi Hamada, Yuichi Obata, Miho Terashima
Publikováno v:
The Journal of Gene Medicine. 7:1148-1157
Background Viral vectors are required as gene-delivery systems for gene therapy and basic research. Recombinant adenoviruses (rAds) expressing genes of interest are being developed as research tools and many studies in vitro and in vivo have already
Autor:
Hong Tang, Yuichi Obata, Miho Terashima, Hideyo Ugai, Makoto Kimura, Takehide Murata, Jianzhi Pan, Kazunari K. Yokoyama, Megumi Hirose, Yukari Kujime, Bingbing Liu, Mujun Zhao, Kumiko Inabe, Takahito Yamasaki, Hirofumi Hamada
Publikováno v:
Biochemical and Biophysical Research Communications. 331:1053-1060
Adenoviruses are excellent vectors for gene transfer and are used extensively for high-level expression of the products of transgenes in living cells. The development of simple and rapid methods for the purification of stable infectious recombinant a
Autor:
Akiko Yoshikawa, Shotaro Kishikawa, Kazuko Ueno, Makoto Kimura, Koji Nakade, Kumiko Inabe, Satoko Masuzaki, Kazunari K. Yokoyama, Chitose Kurihara, Yukari Kujime, Takehide Murata, Yuri Nakano, Jianzhi Pan, Megumi Hirose, Takahito Yamasaki, Masato Okubo, Yuka Kusa, Hideyo Ugai, Yuichi Obata
Publikováno v:
Experimental animals. 59(2)
Genetic materials are one of the most important and fundamental research resources for studying biological phenomena. Scientific need for genetic materials has been increasing and will never cease. Ever since it was established as RIKEN DNA Bank in 1
Autor:
Sanae Watanabe, Takahito Yamazaki, Hideyo Ugai, Erika Suzuki, Jianzhi Pan, Takehide Murata, Megumi Hirose, Yukari Kujime, Kazunari K. Yokoyama
Publikováno v:
Oncology reports. 11(1)
Recombinant adenoviral vectors have been developed for use as therapeutic agents and for the introduction of exogenous genes into living cells. However, the occurrence of replication-competent adenoviruses (RCA) in adenovirus stocks produced in 293 c
Autor:
Kazunari K. Yokoyama, Takehide Murata, Yukari Kujime, Kumiko Inabe, Sanae Inamoto, Megumi Hirose, Erika Suzuki, Takahito Yamasaki, Miho Terashima, Hideyo Ugai
Publikováno v:
Science. 307:1722-1722
Viral vectors have been developed as therapeutic agents for the introduction of exogenous genes into living cells ([1][1]), and clinical trials of gene therapy and the use of viral vectors in the laboratory have been reported with increasing frequenc